Martingale Asset Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.94M	Buy	69,342 +15,710	+29%	+$515K	0.05%	354
2025 Q4	$2.01M	Buy	53,632 +2,203	+4%	+$72.4K	0.05%	314
2025 Q3	$1.42M	Buy	51,429 +2,431	+5%	+$83.7K	0.04%	404
2025 Q2	$1.55M	Buy	48,998 +3,286	+7%	+$106K	0.04%	363
2025 Q1	$1.52M	Buy	45,712 +8,113	+22%	+$291K	0.04%	368
2024 Q4	$1.29M	Buy	37,599 +2,816	+8%	+$96.8K	0.03%	416
2024 Q3	$1.39M	Buy	34,783 +14,946	+75%	+$525K	0.03%	396
2024 Q2	$598K	Buy	+19,837	New	+$596K	0.01%	567
2023 Q4	–	Sell	-11,240	Closed	-$368K	–	814
2023 Q3	$368K	Hold	11,240	–	–	0.01%	654
2023 Q2	$396K	Sell	11,240 -14,533	-56%	-$502K	0.01%	655
2023 Q1	$841K	Hold	25,773	–	–	0.02%	485
2022 Q4	$1.42M	Buy	25,773 +196	+0.8%	+$10.8K	0.03%	351
2022 Q3	$1.13M	Buy	25,577 +4,755	+23%	+$232K	0.02%	403
2022 Q2	$1.02M	Buy	20,822 +799	+4%	+$36K	0.02%	462
2022 Q1	$975K	Buy	20,023 +3,302	+20%	+$135K	0.01%	487
2021 Q4	$713K	Buy	+16,721	New	+$666K	0.01%	566